Merck KGaA suffers CDMO slump after 'sharp drop' in COVID-related sales, CFO says
Fierce Pharma
AUGUST 3, 2023
The division took a major hit from production timing and COVID-related sales downturns.
Fierce Pharma
AUGUST 3, 2023
The division took a major hit from production timing and COVID-related sales downturns.
Let's personalize your content